Institute for the Advancement of Minority Health Partners With CareSimple to Tackle Maternal & Infant Health in Rural Mississippi

2 years ago

The collaboration, part of HRSA's RMOMS program, harnesses innovative solutions to address disparities in maternal care, emphasizing early risk identification…

Bausch Health Announces 2024 Annual Meeting of Shareholder Results

2 years ago

LAVAL, QC / ACCESSWIRE / May 15, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the results of its…

Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA’s Potential Market

2 years ago

Study to evaluate clinical effectiveness of low-dose oral interferons in treating chronic gingivostomatitis in cats, building upon VELDONA's history in…

LFTD Partners Inc. Reports First Quarter 2024 Financial Results

2 years ago

JACKSONVILLE, FL / ACCESSWIRE / May 15, 2024 / LFTD Partners Inc. ("LFTD Partners" or the "Company") (OTCQB:LIFD), the corporate…

Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform

2 years ago

OTA capability enhances introduction of new assays from rapidly expanding menuANN ARBOR, MI / ACCESSWIRE / May 15, 2024 /…

NanoViricides Has Filed its Quarterly Report

2 years ago

NV-387 Advancing to Phase II Clinical Trial for the Treatment of RSV Infection SHELTON, CT / ACCESSWIRE / May 15,…

Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024

2 years ago

HAMBURG, GERMANY / ACCESSWIRE / May 15, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO)…

Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa

2 years ago

ST. LOUIS, May 15, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for…

CloudMD Announces Go-Private Transaction with CPS Capital

2 years ago

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, Frankfurt: 6PH) (the “Company” or “CloudMD”),…

Inhibikase Therapeutics Announces Request for Withdrawal of S-1 Registration Statement

2 years ago

BOSTON and ATLANTA, May 15, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical…